A notable increase in serum IL‐1β, IL‐18, and IL‐6 levels was observed in atherosclerosis mice, and METTL3 knockdown in atherosclerosis mice significantly decreased these inflammatory markers. This evidence concerns the gene METTL3 and atherosclerosis.